Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/medicine-news-1/mindray-announces-third-quarter-2009-financial-results-61027-4/;/a><br) was not found.

Search medicine news 1 mindray announces third quarter 2009 financial results 61027 4 ; a><br at Google

Search medicine news 1 mindray announces third quarter 2009 financial results 61027 4 ; a><br at Yahoo

Search medicine news 1 mindray announces third quarter 2009 financial results 61027 4 ; a><br at Msn

Google
 
(Date:12/1/2009)...nnas aren,t just for listening to the radio anymor...GPS devices. Research from North Carolina State Un...esign creating shape-shifting antennas that open ...rom public safety to military deployment. , Mode...but there are limitations to how far they can be b...
(Date:11/30/2009)...rst comprehensive review of the state of Antarctic...mate system is published this week (Tuesday 1 Dece...earch (SCAR). The review - Antarctic Climate Chan...ch from the icy continent, identifies areas for fu... questions that policy makers have about Antarctic...
(Date:11/30/2009)... of scientists from The Forsyth Institute, the Uni...the Wadsworth Center, have used state-of-the-art t...of Treponema pallidum, the bacterium which causes ...e of the bacteria can now be shown in three dimens...thogen and reveals previously unknown features, wh...
Breaking Biology News(10 mins):Shape shifters: Researchers create new breed of antennas 2First comprehensive review of the state of Antarctica's climate 2Scientists gain new understanding of disease-causing bacteria 2New Shape HF Cardiopulmonary Testing System to be on Display at the Heart Failure Society of America 13th Annual Scientific Meeting September 13 16 56506 1New Shape HF Cardiopulmonary Testing System to be on Display at the Heart Failure Society of America 13th Annual Scientific Meeting September 13 16 56506 2New Shape HF Cardiopulmonary Testing System to be on Display at the Heart Failure Society of America 13th Annual Scientific Meeting September 13 16 56506 3First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 1First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 2First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 3Cell Therapeutics Inc s 28CTI 29 Rodman 26 Renshaw Healthcare Conference Presentation to be Webcast 56502 1
(Date:12/1/2009)...RESEARCH TRIANGLE PARK, N.C., Dec. 1 /PRNewswire/ ...2001 and have expanded over the years serving the ...cility which was originally set up in an area of 2...ices, as part of the suite of services by Max Neem...s a valuable offering. ,, The pharmacy inventor...
(Date:12/1/2009)...SHINGTON, Dec. 1 Indivi...more likely than those with traditional coverage t... be more engaged in wellness programs, and to be m...tter in holding down costs, according to survey re...enefit Research Institute (EBRI). ,, At the sa...
(Date:12/1/2009)...ORT LAUDERDALE, Fla., Dec. 1 Orbus...rollment in the randomized clinical trial of the C... Stent). ,, A prospective, randomized, multicen...of an ablu M inal sirolimus coat ED bio- E ...p to 20 sites in Asia, Australia, Europe and South...
(Date:12/1/2009)...ients in California are unable to successfully obt...hospitals despite recent state legislation intende...w study. , Posing as low-income uninsured patien... than one-third of the hospitals they approached a...han those allowed under California law, according ...
(Date:12/1/2009)... Lumension announces general availabilit...e to deliver end-to-end endpoint management capabi... management console architecture. , ... -- Lumension, a global leader in endpoint managem...n® Endpoint Management and Security Suite (LEM...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 3Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 4Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 5Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 6
HSV 1 IgG ELISA Kit from Biomeda Corporation
Mouse Anti-Human Laminin beta-1 / gamma-1 complex Monoclonal Antibody, Unconjugated, Clone 612C10 from Santa Cruz Biotechnology, Inc.
DONKEY SERUM (WITH 0.09% AZIDE) from AbD Serotec
Anti-Epstein-Barr Virus (EBV) (EBNA-1) Polyclonal Antibody, Biotin Conjugated from ViroStat Inc.
Biology Products:
Continuous Flow Cystoscopes
Prolieve™ Thermodilatation System
The Prostatron® System
...Targis® System uses Cooled ThermoTherapy® ... to deliver precisely targeted microwave energy de...ulative necrosis for durable clinical outcomes. Du...urethral and rectal temperatures for optimal thera...
Medicine Products:
(Date:11/30/2009)...ewswire/ -- Acuo Technologies, developers of high-...a migration tools and services, today announced co...new Vendor Neutral Archive (VNA), providing the fo...k of hospitals, clinics and affiliates. ,, The ...es DICOM Services Grid(TM) Software. The Acuo VNA...
(Date:11/30/2009)...v. 30 Good Publication Practice 2 ...n of company-sponsored medical research, has been ...nal (BMJ). "The publication of GPP2 in BMJ is stro...ort and guidance for industry sponsored research a...viewed medical literature," said Chris Graf, Assoc...
(Date:11/30/2009)...ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall/ --,Ch...ard: CYXN; ,China Yongxin,Pharmaceuticals, or ,the...d,retailer of pharmaceuticals in Northeastern Chin...r distribution of medicines on the Essential Drug ...ormalized the nation,s Essential Drug,List which c...
(Date:11/30/2009)...roviding smart and efficient software to the precl... evolutionizing work-from-home histopathology by u...ware used by 8 of the Top 10 Pharmaceutical Compan...squo; basis. , Mount Arli...ounced another evolution in the histopathology rea...
Breaking Biology Technology:Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3
(Date:12/1/2009)..., , TAI,AN, China, Dec. 1 /PR...s, Inc. (OTC Bulletin Board: CBPO) (Nasdaq: CBPO ... leading plasma-based biopharmaceutical companies ...eived approval to list its,common stock on the NAS...ts its shares to begin trading on the NASDAQ on,We...
(Date:12/1/2009)..., , BEIJING, Dec. 1 /PRNewswire...eading provider of biopharmaceutical products in C...rth purchase order for its H1N1 vaccine, PANFLU.1(...tion Technology for the national,purchase plan. Un...oduce an,additional one million doses of PANFLU.1 ...
(Date:12/1/2009)..., , ROCKVILLE, Md., Dec. 1 /PRNewswire-Fi...NDA ) announced today that the waiting period has ...t Improvements Act of 1976 with respect to Vanda,s...Pharma AG, and that the agreement is now effective...ting effectiveness of the agreement, triggers an u...
Breaking Medicine Technology:China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Light at the speed of a bicycle and much more 56500 1Light at the speed of a bicycle and much more 56500 2Sinapis Pharma Announces Frederick Frank as Consultant 56499 1Sinapis Pharma Announces Frederick Frank as Consultant 56499 2Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 1Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 2